Call for Abstract
Scientific Program
11th World Congress and Expo on Cell & Stem Cell Research, will be organized around the theme “Stem Cell Research- Hope against hype
Mail us at : cellandstemcell@usaconference.org”
Stem Cell Conference 2019 is comprised of 22 tracks and 132 sessions designed to offer comprehensive sessions that address current issues in Stem Cell Conference 2019.
Submit your abstract to any of the mentioned tracks. All related abstracts are accepted.
Register now for the conference by choosing an appropriate package suitable to you.
Tissue engineering can be defined as the use of a combination of cells, engineering materials, and suitable biochemical factors to improve or replace biological functions in an effort to improve clinica l procedures for the repair of damaged tissues and organs.
- Track 1-1Trends & Applications In Tissue Engineering
- Track 1-2Scaffolds In Regenerative Medicine
- Track 1-3Tissue Repair And Regeneration
- Track 1-4Stem Cells Progress In In situ Revascularization And Grafting
- Track 1-5Regeneration Manufacturing Challenges for Regenerative Medicine
- Track 2-1
- Track 2-2
- Track 2-3
- Track 2-4
- Track 2-5
The regulation of stem cell research is an issue that has drawn much comment, criticism and even judicial arbitration in recent years.
- Track 3-1Ethical Issues In Stem Cell Research
- Track 3-2Key Ethical Issues In Embryonic Stem Cell
- Track 3-3IPR
- Track 3-4Biosafety And rDNA Guidelines
- Track 3-5Governing Stem Cell Therapy And Fundings
Gene therapy is an experimental technique that uses genes to treat or prevent disease. In the future, this technique may allow doctors to treat a disorder by inserting a gene into a patient’s cells instead of using drugs or surgery.
- Track 4-1Types of Gene Therapy
- Track 4-2Gene Therapy Techniques
- Track 4-3Gene Therapy Challenges
- Track 4-4
- Track 4-5
- Track 4-6
- Track 4-7
The stem cell field in veterinary medicine continues to evolve rapidly both experimentally and clinically. Stem cells are most commonly used in clinical veterinary medicine in therapeutic applications for the treatment of musculoskeletal injuries in horses and dogs. New technologies of assisted reproduction are being developed to apply the properties of spermatogonial stem cells to preserve endangered animal species.same methods can be used to generate transgenic animals for production of pharmaceuticals or for use as biomedical models
- Track 5-1Cell Based Therapy In Veterinary Medicine
- Track 5-2Bio Science And Clinical Applications of Stem Cells In Veterinary Medicine
- Track 5-3Stem Cells And Regeneration In Veterinary Science
Regenerative medicine is a branch of translational research in tissue engineering and molecular biology which deals with the "process of replacing, engineering or regenerating human cells, tissues or organs to restore or establish normal function.
- Track 6-1Regenerative Approaches With Nanoparticles
- Track 6-2Decellularization
- Track 6-3Blastocyst Complementation
- Track 6-4Reprogramming And Creating Stem Cells
- Track 6-5Advanced Developments In Artificial Organ System
Stem cell plasticity refers to the ability of some stem cells to give rise to cell types, formerly considered outside their normal repertoire of differentiation for the location where they are found. Included under this umbrella title is often the process of “transdifferentiation” – the conversion of one differentiated cell type into another, and metaplasia – the conversion of one tissue type into another.
- Track 7-1Epithelial To Mesenchymal Plasticity And Stem Cells
- Track 7-2Mechanism of Cellular Plasticity
- Track 7-3Adaptive Cellular Reprogramming
- Track 8-1Nanotechnology In The Regeneration of Complex Tissues
- Track 8-2Regenerative Approaches With Nanoparticles
- Track 8-3
- Track 8-4
- Track 8-5
Cancer cells are cells gone wrong in other words, they no longer respond to many of the signals that control cellular growth and death. Cancer cells originate within tissues and, as they grow and divide, they diverge ever further from normalcy. Over time, these cells become increasingly resistant to the controls that maintain normal tissue and as a result, they divide more rapidly than their progenitors and become less dependent on signals from other cells. Cancer cells even evade programmed cell death, despite the fact that their multiple abnormalities would normally make them prime targets for apoptosis. In the late stages of cancer, cells break through normal tissue boundaries and metastasize to new sites in the body
- Track 9-1Therapeutic Target For Cancer
- Track 9-2Hormone Therapies
- Track 9-3Histology
- Track 9-4Pathology
- Track 9-5Cancer Stem Cells And Drug Resistance
A disease model is an animal or cells displaying all or some of the pathological processes that are observed in the actual human or animal disease. Studying disease models aids understanding of how the disease develops and testing potential treatment approaches. |
- Track 10-1Astrocyte Differentiation And Stem Cells
- Track 10-2Modeling Human Disease With Pluripotent Stem Cells
- Track 10-3Adult Stem cells And Embryonic Stem Cells In Disease Modelling
- Track 10-4Induced Pluripotent Stem Cells Greatest Utility For Disease Modelling
- Track 10-5Stem Cell Role In Toxicity Testing
- Track 10-6Loaded Polymeric Nanoparticles Stem Cells
- Track 10-7Autologus MSCs In Veterinary Applications
- Track 10-8Computational Tools for Stem Cell Biology
- Track 11-1
- Track 11-2
- Track 11-3
- Track 11-4
Cell signaling is part of any communication process that governs basic activities of cells and coordinates all cell actions. The ability of cells to perceive and correctly respond to their microenvironment is the basis of development, tissue repair, and immunity, as well as normal tissue homeostasis. Errors in signaling interactions and cellular information processing are responsible for diseases such as cancer, autoimmunity, and diabetes. By understanding cell signaling, diseases may be treated more effectively and, theoretically, artificial tissues may be created.
- Track 12-1Crosstalk
- Track 12-2Cell Signaling Dynamics
- Track 12-3Modern Approach in Cell Signaling
- Track 12-4Cell Adhesion and Cell Communication
- Track 12-5Immune Signaling
Stem cell transplantation, sometimes referred to as bone marrow transplant, is a procedure that replaces unhealthy blood-forming cells with healthy cells. Stem cell transplants commonly are used to treat Leukemia and lymphoma, cancers that affect the blood and lymphatic system.
- Track 13-1Allogeneic Bone marrow Transplantation
- Track 13-2Hematopoietic Stem Cell Transplantation
- Track 13-3 Myelodysplastic syndrome and drug therapy
- Track 13-4 Challenges in Transplanting Stem Cells
- Track 14-1Protection of human stem cells
- Track 14-2Stem cell and insulin
- Track 14-3Hematopoietic malignancies
- Track 14-4Immune cells regulate blood stem cells
Stem-cell therapy is the use of stem cells to treat or prevent a disease or condition.The most well-established and widely used stem cell treatment is the transplantation of blood stem cells to treat diseases and conditions of the blood and immune system, or to restore the blood system after treatments for specific cancers.
- Track 15-1Autoimmune Disease Stem Cell Treatment
- Track 15-2Blood And Skin Diseases
- Track 15-3Organ Cancer: Gastric cancer, Breast, Oral, Head And Neck Cancer
- Track 15-4Lymphoma
- Track 15-5Alzheimers And Stem Cells
- Track 15-6Periodontal Diseases And Stem Cells
Stem Cell Biomarker is characterized as a quality or their proteins that are utilized to disengage and recognize immature microorganisms. The other approach to distinguish the undifferentiated organisms is by utilizing utilitarian assays. Molecular biomarkers serve as profitable apparatuses to arrange and segregate embryonic immature microorganisms (ESCs) and to screen their separation state by immunizer based systems. ESCs can offer ascent to any grown-up cell sort and in this way offer colossal potential for regenerative medication and drug revelation. Various biomarkers, for example, certain cell surface antigens, are utilized to dole out pluripotent ESCs
- Track 16-1 Stem Cell Markers
- Track 16-2Biomarkers And Cancers
- Track 16-3Organ Cancer: Pancreatic Cancer, Colorectal Cancer, Breast , Oral, Head And Neck Cancer.
- Track 16-4Cancer Therapeutics
Stem cell therapy is a type of cell therapy in which therapeutic efficacy exclusively attributed to the potency (function) of donor stem cells, presented in any quantity and purity. Bone marrow transplant is the most widely used stem-cell therapy, but some therapies derived from umbilical cord blood are also in use.
- Track 17-1Allogenic cell therapy
- Track 17-2Human embryonic stem Cells
- Track 17-3Neural stem cell Therapy
- Track 17-4Messenchymal stem cell therapy
- Track 17-5Haematopoietic stem cell transplantation
- Track 17-6Specific Cancer Immunotherapy
- Track 17-7Translational Studies For Cancer Stem Cell-Based Therapies
- Track 17-8Ubiquitination Pathways For Cancer Therapy
- Track 17-9Enantioselectivity And Chiral Complexing In Cancer Therapy
Embryonic stem (ES) cells are cells derived from the early embryo that can be propagated indefinitely in the primitive undifferentiated state while remaining pluripotent; they share these properties with embryonic germ (EG) cells. Candidate Embryonic stem and embryonic germ cell lines from the human blastocyst and embryonic gonad can differentiate into multiple types of somatic cell.
- Track 18-1Molecular Alterations During Female Reproductive Aging
- Track 18-2Role of Sperm DNA Integrity In Fertility
- Track 18-3Fertilization And Infertility
- Track 18-4Embryo Implantation
- Track 18-5Role of Macrophages In The Placenta
- Track 18-6Factors of Human Implantation
- Track 18-7Stimulus Trigerred Acquisition of Pluripotency (STAP)
Self-reestablishment and multiplication of foundational microorganism populaces is controlled, to some degree, by affectation of apoptosis. The quantity of foundational microorganisms is thusly a harmony between those lost to separation/apoptosis and those increased through multiplication. Apoptosis of immature microorganisms is accepted to be a dynamic procedure which changes because of natural conditions.
- Track 19-1Genomic Analysis And Molecular Basis of Cancer
- Track 19-2Cancer Stem Cells And Impaired Apoptosis
- Track 19-3Inflammatory Diseases And Cancer
- Track 19-4 Epigenetics And Cancer Stem Cells
- Track 19-5Apoptosis And Haematopoietic Stem Cells
- Track 20-1Amniotic Stem Cell Bank
- Track 20-2Umbilical Cord Blood Banks
- Track 20-3Hematopoietic Stem Cell And Potential Non-Hematopoietic Stem Cells
- Track 20-4Invivo & Invitro Stem cell Microenvironment
- Track 20-5Cancer Stem Cell Niche
- Track 20-6Extracellular Matrix Mimicking strategies for Stem cell Niche
The study of changes in organisms caused by modification of gene expression rather than alteration of the genetic code itself. Epigenetics are stable heritable traits that cannot be explained by changes in DNA sequence.
- Track 21-1Bone Remodeling And Osteoporosis
- Track 21-2Single-cell Technology In Cancer Research
- Track 21-3Stem Cell Epigenetics And Disease
- Track 21-4Epigenetic regulation of stem cells differentiating
Stem cells: An undifferentiated cell of a multicellular organism which is capable of giving rise to indefinitely more cells of the same type, and from which certain other kinds of cell arise by differentiation. Stem cells have the ability to differentiate into specific cell types. The two defining characteristics of a stem cell are perpetual self-renewal and the ability to differentiate into a specialized adult cell type. There are two major classes of stem cells: pluripotent that can become any cell in the adult body, and multipotent that are restricted to becoming a more limited population of cells.
- Track 22-1Embryonic stem cells
- Track 22-2Non-embryonic (adult) stem cells
- Track 22-3Induced pluripotent stem cells (iPSCs)
- Track 22-4Cord blood stem cells and amniotic fluid stem cells
- Track 22-5Tissue Stem Cells